Come up with a name for your new list and we'll add to it:
Saegis Pharmaceuticals was acquired by
H. Lundbeck on December 20, 2006.
Saegis Pharmaceuticals is a leader in the development of next generation medicines to improve memory and cognition deficits associated with human Central Nervous System (CNS) diseases. As the first co…